Novel N1 or N9 modified α-carboline analogues as potential ligands in Alzheimer's disease therapy: Synthesis and neurobiological activity evaluation.
Alzforum,
Dan W, Cao Y, Sun Y, Zhang J, Liu J, Gao J, Han R, Dai J. Bioorg Chem. 2023 Jan 18;133:106378.